| scholarly article | Q13442814 |
| P2093 | author name string | Leslie Baumann | |
| Steven Dayan | |||
| Conor J Gallagher | |||
| Xiaofang Lei | |||
| Simon Connolly | |||
| Adrienne Drinkwater | |||
| Nancy Silverberg | |||
| P2860 | cites work | Botulinum toxin: examining duration of effect in facial aesthetic applications | Q30980391 |
| Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study. | Q33206862 | ||
| Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin | Q34615234 | ||
| Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology | Q36152069 | ||
| Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products | Q37923924 | ||
| A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines | Q44027123 | ||
| A Prospective, Double-Blind, Randomized, Parallel- Group, Dose-Ranging Study of Botulinum Toxin Type A in Female Subjects With Horizontal Forehead Rhytides | Q44444578 | ||
| Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines | Q44584439 | ||
| Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes | Q46240505 | ||
| Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial | Q46530765 | ||
| OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines | Q46612347 | ||
| Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial | Q46628313 | ||
| OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines | Q47724519 | ||
| Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. | Q53406718 | ||
| Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling | Q68039039 | ||
| Botulinum toxin for the treatment of hyperfunctional lines of the face | Q72894311 | ||
| Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study | Q81358703 | ||
| Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet | Q81669057 | ||
| P433 | issue | 5 | |
| P921 | main subject | botulinum toxin type A | Q4095199 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 598-607 | |
| P577 | publication date | 2016-04-21 | |
| P1433 | published in | Dermatologic Surgery | Q15752669 |
| P1476 | title | Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials | |
| P478 | volume | 42 |
| Q36331330 | A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging |
| Q49825762 | Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY Study |
| Q91829670 | Real-World Safety And Effectiveness Of OnabotulinumtoxinA Treatment Of Crow's Feet Lines And Glabellar Lines: Results Of A Korean Postmarketing Surveillance Study |
Search more.